Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 2 ... priorities' in Brazil. GSK will transfer technology for the production of its 10-valent conjugate vaccine for paediatric pneumococcal disease Synflorix as well as establishing a research and ...
2009 OCT 19 ... has developed a proprietary technology that allows the engineering of a new type of conjugate vaccine, glycoconjugates. This innovation will enable GlycoVaxyn to address significant unmet ...
2009 SEP 21 ... death, depending on the dose of cells transferred. In addition, the tetramer-saporin conjugate also reduced liver damage in a model of donor T-cell-mediated hepatic destruction. These ... to MHC tetramers," wrote P. Penaloza-MacMaster and colleagues, Emory University, Emory Vaccine Center. The researchers concluded: "Also, the results suggest that it may ...
2009 NOV 16 ... 11 countries have received GAVI Alliance approval for support to introduce pneumococcal conjugate vaccine (PCV) and 12 additional countries have submitted applications. "For the ...
Subject: The Global Coalition against Child Pneumonia
2009 SEP 28 ... 11 countries had received GAVI Alliance approval for support to introduce pneumococcal conjugate vaccine (PCV), including 8 in Africa and Asia. Two of these, Rwanda and the Gambia, have now ...
2009 NOV 2 ... epitopes and to a biepitope ( includes 2F5 and 4E10 epitopes) MPER peptide-liposome conjugate was best described by a two-step encounter-docking model. Analysis of the binding ... information, contact S.M. Alam, Duke University, School Medical, Dept. of Medical, Human Vaccine Institute, 106 Research Dr., MSRBII, Durham, NC 27710, USA. Publisher ...
2009 NOV 24 ... vaccine (PPV) is recommended for elderly persons, the potential benefits of conjugate vaccine use in this age group remain unclear," scientists in London, the United Kingdom report. ...
2009 NOV 23 ... of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain.' According to a study from Spain, "The present study evaluated ...
2009 NOV 2 ... Journal of Respiratory and Critical Care Medicine (Superior Immune Response to Protein-Conjugate versus Free Pneumococcal Polysaccharide Vaccine in Chronic Obstructive Pulmonary ...
2009 NOV 23 ... attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine.' According to recent research from Oeiras, Portugal, "The seven-valent pneumococcal ...
2009 NOV 2 ... A study published in The Cochrane Review this month concludes that pneumococcal conjugate vaccines (PCV), already known to prevent invasive pneumococcal disease (IPD) and x-ray ... Africa, Philippines, and Finland. Eighty percent of children were less likely to develop vaccine-type IPD, 58% all-serotype IPD, and 27% x-ray defined pneumonia than children who did ...
Subject: Johns Hopkins University Bloomberg School of Public Health
2009 NOV 16 ... infants from the United States were enrolled to receive the quadrivalent, meningococcal conjugate vaccine (MCV4) at 9 months of age and then MCV4 concomitantly with the measles-mumps-rubella ...
2009 NOV 17 ... the United States conducted a study "To examine the effect of the 7-valent pneumococcal conjugate vaccine In a well-characterized population In Olmsted County, Minnesota, with a combination of ...
2009 SEP 28 ... also received pretransplant and posttransplant immunizations using a pneumococcal conjugate vaccine only (arm B; n = 24) or the pneumococcal...
2009 NOV 25 ... "In The Netherlands, a single meningococcal serogroup C conjugate (MenCC) vaccination is administered to children at the age of 14 months. Here, we report ... Devoer and colleagues published their study in Clinical and Vaccine Immunology (Absence of Neisseria meningitidis Serogroup C-Specific Antibodies during the ...
2009 NOV 23 ... recommendation for vaccination of German children <2 years with the pneumococcal conjugate vaccine was issued at the end of July 2006," investigators in Aachen, Germany report. ...
2009 NOV 2 ... becoming the first government to approve Wyeth's Prevenar PCV13, a pneumococcal 13-conjugate vaccine for infants and young children, in July 2009. According to our BoDD, 2,977 ...
2009 SEP 14 ... hence do not suffer from immune suppression observed with classical carbohydrate-protein conjugate vaccines. Such vaccines are chemically well-defined and it is to be expected that they ... of oligosaccharides and glycopeptides is providing avenues for the rationale design of vaccine candidates." "In this respect, fully synthetic vaccine candidates show ...
2009 OCT 12 ... for Human Use (CHMP) has issued a positive opinion for the company's pneumococcal conjugate vaccine, Prevenar 13* (Pneumococcal Polysaccharide...
